Related Experiment Video
Updated: Jun 5, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
Published on: May 23, 2025
[Susceptibility-weighted imaging in detecting brain iron accumulation of Parkinson's disease]
Xin-Ming Huang1, Bin Sun, Yun-Jing Xue
1Department of Magnetic Resonance Imaging, the Union Hospital Affiliated of Fujian Medical University, Fuzhou 350001, China.
Objective:
to evaluate the clinical value of susceptibility-weighted imaging (SWI) in the measurement of brain iron in Parkinson's disease at 3.0 Tesla MRI.
Methods:
a total of 30 patients with clinical diagnosis Parkinson's Disease (PD) and 19 age-matched normal controls took the brain MR examination with conventional and SWI sequences. PD patients were classified into two groups according to I-IV stage (Hoehn-Yahr) and disease duration (≤ 5 year, > 5 year) respectively. Region of interest (ROI) were handed drawn on phase images, including putamen (PUT), globus pallidus (GP), caudate nucleus (CN), substantia nigra (SN), and red nucleus (RN), and corresponding signals and phase values were measured. Two-sample t-test was used for comparison between patients groups and normal controls. P values of < 0.05 were considered statistically significant.
Results:
the mean phase values of SN (P = 0.01), GP (P < 0.01) in PD group was significantly different from those in normal controls. However, PUT, CN and RN had no significant differences between patient group and normal controls. Phase values of SN in Hoehn-Yahr III-IV was significantly different from those I-II (P = 0.000), (did not correlated with disease duration). Using phase value of -0.11 as the threshold value, the sensitivity of diagnosis of PD was 60.0% (18/30), the specificity was 57.9% (11/19), the accuracy was 59.2% (29/49).
Conclusions:
SWI provided a non-invasive semi-quantitative method for iron deposition study in PD and it may help us to trace the iron development in PD.
Insights
Susceptibility-weighted imaging (SWI) shows altered brain iron in Parkinson's disease (PD) patients, particularly in the substantia nigra and globus pallidus. This non-invasive MRI technique may help track iron accumulation in PD progression.
Area of Science:
- Neuroimaging
- Neurodegenerative Diseases
- Biomarkers
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor symptoms and the progressive loss of dopaminergic neurons.
- Iron accumulation in specific brain regions is increasingly recognized as a potential factor in PD pathogenesis.
- Accurate measurement of brain iron is crucial for understanding PD progression and developing therapeutic strategies.
Purpose of the Study:
- To assess the clinical utility of susceptibility-weighted imaging (SWI) for quantifying brain iron deposition in Parkinson's disease (PD) using 3.0 Tesla MRI.
- To investigate the correlation between iron levels measured by SWI and PD severity (Hoehn-Yahr stage) and disease duration.
Main Methods:
- A cohort of 30 PD patients and 19 healthy controls underwent 3.0T brain MRI with conventional and SWI sequences.
- Regions of interest, including substantia nigra (SN) and globus pallidus (GP), were manually delineated on phase images.
- Phase values were measured in these regions, and statistical analyses (two-sample t-test) were performed to compare groups.
Main Results:
- Significantly higher mean phase values, indicative of increased iron deposition, were observed in the substantia nigra (SN) and globus pallidus (GP) of PD patients compared to controls.
- No significant differences in iron deposition were found in the putamen (PUT), caudate nucleus (CN), or red nucleus (RN).
- SN phase values were significantly higher in PD patients with Hoehn-Yahr stage III-IV compared to those with stage I-II, but did not correlate with disease duration.
Conclusions:
- Susceptibility-weighted imaging (SWI) offers a non-invasive, semi-quantitative method for evaluating brain iron deposition in Parkinson's disease.
- SWI may serve as a valuable tool for monitoring iron accumulation and its potential role in the progression of PD.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Neural Regulation

